333
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Recurrent miscarriage and hCG supplementation: a review and metaanalysis

Pages 712-716 | Received 31 Mar 2010, Accepted 21 Apr 2010, Published online: 23 Jul 2010

References

  • Stirrat GM. Recurrent miscarriage. Lancet 1990;336:673–675.
  • Horta JLH, Fernandez JG, DeSoto LB. Direct evidence of luteal insufficiency in women with habitual abortion. Obstet Gynecol 1977;49:705–708.
  • Csapo AI, Pulkkinen MO. Indispensability of the human corpus luteum in the maintenance of early pregnancy: Lutectomy evidence. Obstet Gynecol Surv 1978;3:69–81.
  • Sandler SW, Baillie P. The use of human chorionic gonadotropin in recurrent abortion. S Afr Md J 1979;19:832–835.
  • Svigos J. Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion. Clin Reprod Fertil 1982;1:131–135.
  • Harrison RF. Treatment of habitual abortion with human chorionic gonadotropin: results of open and placebo-controlled studies. Eur J Obstet Gynecol Reprod Biol 1985;20:159–168.
  • Harrison RF. Human chorionic gonadotrophin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 1992;47:175–179.
  • Quenby S, Farquharson RG. Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial. Fertil Steril 1994;62:708–710.
  • El-Zibdeh MY. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 2005;97:431–434.
  • Carp HJA. hCG supplementation in recurrent miscarriage: pros and cons. In: Kumar A, Rao CV, Chaturvedi PK, editors, Rahman N, Halder A, co-editors. Gonadal and nongonadal actions of gonadotropins. New Delhi: Narosa Publishing House; 2010. pp 171–180.
  • Scott JR, Pattison N. Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev 2000; CD000101.
  • Carp HJA. Recurrent pregnancy loss: towards more accurate diagnosis and treatment. Isr Med Assoc J 2001;3:528–532.
  • Daya S, Gunby J. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:294–302.
  • Carp HJA. Investigation protocol for recurrent pregnancy loss. In: Carp HJA editor. Recurrent pregnancy loss, causes, controversies and treatment. London, UK: Informa Healthcare Ltd; 2007. pp 269–280.
  • Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000;73:300–304.
  • Kovalevskaya G, Genbacev O, Fisher SJ, Cacere E, O'Connor JF: Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol 2002;194:147–155.
  • Sasaki Y, Ladner DG, Cole LA: Hyperglycosylated hCG the source of pregnancy failures. Fertil Steril 2008;89:1871–1786.
  • Hanson FW, Powell JE, Stevens VC. Effects of hCG and human pituitary LH on steroid secretion and functional life of the corpus luteum. J Clin Endocrinol 1971;32:211–215.
  • Han SW, Lei ZM, Rao ChV. Up-regulation of cyclooxygenase-2 gene expression by chronic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 1996;137:1791–1797.
  • Chatterjee A, Jana NR, Bhattacharya S. Stimulation of cyclic AMP, 17β oestradiol and protein synthesis by human chorionic gonadotropin in human endometrial cells. Hum Reprod 1997;12:1903–1908.
  • Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 2009;26:7–8. Review.
  • Goldsmith LT, Weiss G, Palejwala S, Plant TM, Wojtczuk A, Lambert WC, Ammur N, Heller D, Skurnick JH, Edwards D, Cole DM. Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc Natl Acad Sci USA 2004;101:4685–4689.
  • Licht P, Lösch A, Dittrich R, Neuwinger J, Siebzehnrübl E, Wildt L. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update 1998;4:532–538.
  • Zygmunt M, Herr F, Keller-Schoenwetter S, Kunz-Rapp M, Munstedt K, Rao ChV, Lang U, Preissner KT. Characterization of human chorionic gonadotropin as an angiogenic factor. J Clin Endocrinol Metab 2002;87:5290–5296.
  • Toth P, Li X, Rao ChV, Lincoln SR, Sanfilippo JS, Spinnato JS, Yussman MA. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab 1994;79:307–315.
  • Kornyei J, Lei ZM, Rao ChV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod 1993;49:1149–1157.
  • Eta E, Ambrus G, Rao ChV. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol Metab 1994;79:1582–1586.
  • Ambrus G, Rao ChV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology 1994;135:2772–2779.
  • Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Human Reprod Update 2006;12:747–755.
  • Sutton-Riley JM, Khanlian SA, Byrn FW, Cole LA: A single serum test for measuring pregnancy outcome with high predictive value. Clin Biochem 2006;39:682–687.
  • Lin J, Lojun S, Lei ZM, Wu WX, Peiner SC, Rao ChV. Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene. Mol Cell Endocrinol 1995;111: R13–R17.
  • Lei ZM, Yang M, Li X, Takikawa O, Rao CV. Upregulation of Placental Indoleamine 2,3-Dioxygenase by Human Chorionic Gonadotropin. Biol Reprod 2007;76:639–644.
  • Chaouat G, Menu E, Wegmann TG. Role of lymphokines of the CSF family and of TNF, gamma interferon and IL-2 in placental growth and fetal survival studied in two murine models of spontaneous resorptions. In: Chaouat G, Mowbray JF, editors. Cellular and molecular biology of the maternal-fetal relationship, Paris: INSERM/John Libbey Eurotext; 1991. p 91.
  • Garcia-Lloret MI, Morrish DW, Wegmann TG, Honore L, Turner AR, Guilbert LJ. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res 1994;214:46–54.
  • Uzumcu M, Coskun S, Jaroudi K, Hollanders JMG. Effect of human chorionic gonadotropin on cytokine production from human endometrial cells in vitro. Am J Reprod Immunol 1998;40:83–88.
  • Schafer A, Pauli G, Friedmann W, Dudenhausen J. Human chorionic gonadotropin (hCG) and placental lactogen (hPL inhibit interieukin-2 and increase IL-1β -6 (IL-6) and tumor necrosis factor (TNFα) expression monocyte cultures. J Perinat Med 1992;20:233–240.
  • Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005;112:1096–1101.
  • Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R. Asymmetric antibodies and pregnancy. Am J Reprod Immunol 2001;45:289–294.
  • Carp HJA, Toder V, Mashiach S, Nebel L, Serr, DM. Early pregnancy loss: current concepts of research and treatment. Obstet Gynecol Survey 1990;45:657–669.
  • Laufer MR, Ecker JL, Hill JA. Pregnancy outcome following ultrasound-detected fetal cardiac activity in women with a history of multiple spontaneous abortions. J Soc Gynecol Investig 1994;1:138–142.
  • Elbling L. Congenital malformations in mice after gonadotropin-induced ovulation. Proc Soc Exp Biol Med 1975;149:376–379.
  • Sakai N, Endo A. Potential teratogenicity of gonadotropin treatment for ovulation induction in the mouse offspring. Teratology 1987;36:229–233.
  • Sairam MR, Kato K, Mukhopadhyay AK, Bohnet HG. Preparation and properties of human chorionic gonadotropin antagonist for biological studies: antifertility effects in the female rat. Acta Endocrinol 1986;112:586–594.
  • Carp HJA. Obstetric outcomes after recurrent pregnancy loss. In: Carp HJA, editor. Recurrent pregnancy loss, causes, controversies and treatment. London, UK: Informa Healthcare Ltd; 2007. pp 231–241.
  • Van de Weijer BH, Mulders JW, Bos ES, Verhaert PD, van den Hooven HW. Compositional analyses of a human menopausal gonadotropin preparation extracted from urine (menotropin). Identification of some of its major impurities. Reprod Biomed Online 2003;7:547–557.
  • Lindqvist P, Grennert L, Marsál K. Epidermal growth factor in maternal urine–a predictor of intrauterine growth restriction? Early Hum Dev 1999;56:143–150.
  • Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005;11:613–630.
  • He S, Pant D, Schiffmacher A, Meece A, Keefer CL. Lef1 Mediated wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 2008;26:842–849.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.